Debt-to-equity of Sensei Biotherapeutics, Inc. from 30 Sep 2021 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Sensei Biotherapeutics, Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2021 to 30 Sep 2025.
  • Sensei Biotherapeutics, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 18%, a 25% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Sensei Biotherapeutics, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 18% +3.7% +25% 30 Sep 2025
Q2 2025 18% +3% +20% 30 Jun 2025
Q1 2025 17% +2.7% +19% 31 Mar 2025
Q4 2024 16% +1.5% +10% 31 Dec 2024
Q3 2024 15% +0.72% +5.1% 30 Sep 2024
Q2 2024 15% +0.98% +7.2% 30 Jun 2024
Q1 2024 14% +1.6% +13% 31 Mar 2024
Q4 2023 14% +2.2% +19% 31 Dec 2023
Q3 2023 14% +4.8% +52% 30 Sep 2023
Q2 2023 14% +6.6% +93% 30 Jun 2023
Q1 2023 13% +7.2% +135% 31 Mar 2023
Q4 2022 12% +8.6% +266% 31 Dec 2022
Q3 2022 9.3% +4.8% +107% 30 Sep 2022
Q2 2022 7% 30 Jun 2022
Q1 2022 5.4% 31 Mar 2022
Q4 2021 3.2% 31 Dec 2021
Q3 2021 4.5% 30 Sep 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.